Theras Group
Theras Group is a privately-held Italian MedTech company founded in 2010 that distributes and supports medical devices and consumer health products for diabetes, chronic pain, weight management, and self-care, reaching 11,000+ Italian pharmacies, 600+ hospitals, and 80+ countries.
- Company typePrivate
- Founded2010
- HeadquartersParma, Italy
- Headcount101–250
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Theras Group does
Theras Group is an Italian privately-held MedTech company founded in 2010 and headquartered in Salsomaggiore Terme, distributing and supporting advanced medical devices and consumer health products for chronic disease management. The company operates through two principal entities: Theras Lifetech S.r.l. unipersonale (the core MedTech distribution arm) and Theras Consumer Health S.r.l. (Milan-based subsidiary for pharmacy retail brands), plus the philanthropic Theras Foundation.
Theras's portfolio spans four therapeutic areas. In diabetes, it distributes the Insulet Omnipod 5 automated insulin delivery system (integrated with Dexcom G6/G7 and FreeStyle Libre 2 Plus CGM sensors), Omnipod DASH, Dexcom G6/G7 CGM, the T-way subcutaneous access port, and the Yup hypoglycemia supplement. In chronic pain, it offers Nevro HFX iQ (AI-enabled) and Nevro Omnia spinal cord stimulation systems, the Nextim percutaneous neurostimulation generator, and the Epimed radiopaque epidural catheter range for epidurolysis. In weight management, it distributes Plenity, an ingestible superabsorbent hydrogel device developed by Gelesis and available in Italian pharmacies without prescription. The Medical Selfcare division is anchored by the Pic Solution brand (60+ years of heritage), covering syringes, needles, wound care, respiratory, and connected home-health devices.
The company monetizes primarily via hardware sales (medical devices and consumer health SKUs) through a dense multi-channel network: more than 11,000 Italian pharmacies, more than 600 Italian hospitals, the Medical Center Italia B2B e-commerce platform, and Pic Solution distribution in 80+ countries. TherasCare wraps the portfolio with a 24/7 toll-free helpline (800 587 270), patient portal, app, AI chatbot (T.rex), and HCP education programs (Theras Academy, Scientific Talks, Digital Talks). The company invests 5% of turnover in R&D and runs the Theras Innovation Factory with academic ties to MIT, Harvard Medical School, Politecnico di Milano, and University of Salento.
Theras Group firmographics
Firmographics- Name
- Theras Group
- Legal name
- Theras Lifetech S.r.l. unipersonale
- Website
- https://theras-group.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Theras Group is a privately-held Italian MedTech company founded in 2010 that distributes and supports medical devices and consumer health products for diabetes, chronic pain, weight management, and self-care, reaching 11,000+ Italian pharmacies, 600+ hospitals, and 80+ countries.
- Ownership category
- akta.pro rank
Theras Group industry classification
Industry- Product category
- Medical Device Distribution and Chronic Disease Management
- NAICS
- Health Care and Social Assistance (62)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Diabetes (General) (HLAKADAA), Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)
Keywords
Where Theras Group is headquartered
LocationHeadquarters
- HQ city
- Parma
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
Theras Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure, Operations
Revenue model
- Medical Device Distribution: Distribution of proprietary and licensed medical devices for diabetes management, chronic pain treatment, and weight management through pharmacies, hospitals, and direct-to-consumer channels.
- Product Portfolio Sales: Sales of diabetes devices (Omnipod, Dexcom), pain management systems (Nevro), weight management (Plenity), and Pic Solution consumer health products through pharmacy network.
- TherasCare Support Services: Patient and healthcare professional support services including 24/7 toll-free hotline, digital portal, chatbot, and educational content.
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Theras Group product offering
Product offeringCore offering
Theras Group distributes and supports an integrated portfolio of medical devices for chronic disease management across diabetes (insulin pumps, continuous glucose monitors, injection access ports), chronic pain (spinal cord stimulation, percutaneous neurostimulation, epidural catheters), and weight management (ingestible hydrogel devices), complemented by a Medical Selfcare line of syringes, wound care, and home health products. The TherasCare ecosystem (24/7 hotline, portal, app, AI chatbot) and professional education programs (Theras Academy, Scientific Talks) provide ongoing patient and clinician support alongside device distribution.
Product overview
Theras Group operates as a MedTech company distributing and supporting a portfolio of medical devices across three therapeutic areas: diabetes management, chronic pain treatment, and weight management, alongside a Medical Selfcare division. The core diabetes portfolio is centered on the Omnipod tubeless insulin pump family (Omnipod 5 with automated insulin delivery and Omnipod DASH), combined with Dexcom G6/G7 continuous glucose monitoring systems and T-way subcutaneous injection access ports, all supported by the TherasCare digital ecosystem. For chronic pain, the company distributes the Nevro HFX iQ and Omnia spinal cord stimulation systems, the Nextim percutaneous nerve stimulation generator, and Epimed radiopaque epidural catheters for epidurolysis. The weight management division features Plenity, an ingestible hydrogel capsule device. The Medical Selfcare division is anchored by the Pic Solution brand covering syringes, needles, diabetes care, wound care, respiratory devices, and home health monitors, distributed through pharmacies and hospitals and via the Medical Center Italia e-commerce platform. TherasCare serves as the overarching support platform for all patient and healthcare professional engagement, combining a portal, app, AI chatbot, and 24/7 helpline, while Theras Academy and Scientific/Digital Talks events provide ongoing professional education.
Differentiator
Problem solved
Functional benefit
Brands
- Pic Solution: Consumer health brand for medical self-care products including syringes, needles, glucose meters, pen needles, wound care, respiratory devices, and health measurement tools. Present in over 11,000 pharmacies in Italy and 80+ countries worldwide.
- TherasCare
- Theras Academy
- Theras Innovation Factory
- Plenity
- T.rex
Products and services
- Omnipod 5 Automated Insulin Delivery (AID) system integrating with Dexcom G6, Dexcom G7, and FreeStyle Libre 2 Plus CGM sensors to automatically modulate insulin infusion based on real-time glucose data, eliminating the need for catheters. Targeted at diabetes patients requiring advanced insulin pump therapy.
- Omnipod DASH Tubeless insulin delivery system consisting of a wearable patch pump applied directly to the skin and a dedicated control device. Delivers insulin continuously via a small subcutaneous cannula for discreet and flexible diabetes management.
- Dexcom G7 Latest-generation continuous glucose monitoring system with subcutaneous sensor, integrated transmitter, and visualization device. Measures glucose every few minutes with real-time values, trends, and high/low alarms 24/7.
- Dexcom G6 Continuous glucose monitoring system for real-time blood glucose tracking. Includes subcutaneous sensor, transmitter, and receiver/display device providing glucose readings, trends, and predictive alerts for diabetes patients.
- T-way Subcutaneous access port for insulin injections that simplifies multi-injection therapy by reducing daily skin punctures. Consists of a small adhesive-mounted device and an applicator for automatic, painless port insertion.
- Yup Liquid dietary supplement with fast-acting properties to help restore normal blood glucose levels during hypoglycemia without causing glycemic rebound. Targeted at diabetes patients managing acute low-glucose episodes.
- Nevro HFX iQ AI-powered Spinal Cord Stimulation (SCS) system for chronic pain management. Delivers high-frequency electrical pulses to the spinal cord to modulate nerve signals responsible for pain perception, reducing pain without inducing paresthesias. For patients with chronic neuropathic pain conditions.
- Nevro Omnia High-frequency spinal cord stimulation system combining all frequencies between 2 Hz and 10,000 Hz, offering HF10 therapy, Burst, Burst10k, and low-frequency modalities for chronic pain treatment in patients refractory to conventional therapies.
- Nextim Pulse generator for percutaneous nerve stimulation designed by Theras for relief of refractory chronic neuropathic pain. Controls up to 3 outputs simultaneously to treat complex pain areas using bipolar electrodes inserted in tissue and removed at session end.
- Epimed Range of radiopaque epidural catheters for epidurolysis procedures to treat chronic pain caused by scar tissue in the epidural space. Includes Racz-type catheters, RX-2 Coudé introducer needles, and BLUNT and BELLA D nerve block needles, designed for fluoroscopic guidance.
- Plenity Medical device in capsule form for weight management with patented super-absorbent hydrogel that absorbs ~100x its weight in water, forming a 3D gel matrix in the stomach that induces early and prolonged satiety. Indicated for overweight adults (BMI 25-29.9) and Class 1-2 obesity (BMI 30-40). Available in Italian pharmacies without prescription.
- Pic Solution Consumer health brand for medical self-care covering a broad range of daily health management solutions including injection devices (syringes, needles), diabetes care (glucose meters, pen needles), wound care dressings, respiratory/aerosol therapy devices, home health measurement devices (thermometers, blood pressure monitors including connected devices with atrial fibrillation detection), and sanitary aids. Present in over 11,000 pharmacies in Italy, 80+ countries, and 600+ Italian hospitals.
- TherasCare Ecosystem Ecosystem of digital and support services for patients, caregivers, and healthcare professionals. Includes a website portal and app providing manuals, videos, webinars, newsletters, the T.rex AI chatbot for digital support, and a 24/7 toll-free customer care helpline (800 587 270).
- Medical Center Italia E-commerce platform dedicated to health and medical professionals, offering an extensive catalogue of medical devices and equipment to support professionals in their practices, laboratories, and patient care.
Quantifiable outcome
- 59% of Plenity patients lost at least 5% body weight in clinical trials
- +3 more outcomes
Companies that use Theras Group
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
Theras Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature5 records
Theras Group partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered minor and core.
- Clust-Er HealthminorCluster organization for health innovation in Emilia-Romagna region, supporting Theras open innovation ecosystem and technology development collaboration.
- MassChallengeminorGlobal innovation accelerator enabling Theras to access emerging technologies and startup innovations in the healthcare space.
- Politecnico di MilanocoreItalian technical university partnership for research collaboration in medical technology development and innovation.
- Osservatori.netminorDigital innovation research platform providing insights on digital transformation trends relevant to healthcare technology.
- Massachusetts Institute of Technology (MIT)coreResearch collaboration with MIT for technology scouting and validation of innovative healthcare solutions for the Italian market.
- Harvard Medical SchoolcoreAcademic partnership for scientific validation and clinical research collaboration in medical technologies.
- GelesiscoreBiotech company specializing in innovative weight control technologies, developer of Plenity superabsorbent hydrogel technology licensed to Theras for Italian distribution.
- Confindustria - Dispositivi MedicicoreActive member and partner of Italian medical devices industry association for sector representation and advocacy.
- Salso VolleyminorLocal volleyball club partnership for Theras for Sport initiative promoting health awareness among young people about chronic diseases.
- Salso VolleyminorPartnership for organizing volleyball tournament under 18 'Vincere fuori dal campo' scheduled for June 13, 2026 to promote health awareness among young people.
- University of SalentocoreAcademic institution where Alessandro Sannino, inventor of Plenity technology, serves as professor of Materials Science. Source of core technology for weight management device.
Scale indicators13 records
Recent moves6 records
Expansion highlights6 records
Theras Group competitors and assessment
Company assessmentBroad incumbents
- Medtronic plc: Global MedTech incumbent with diabetes (insulin pumps, CGM) and chronic pain (spinal cord stimulation) franchises that directly overlap with Theras's Omnipod/Dexcom and Nevro portfolios.
- Roche Diabetes Care: Diabetes device and digital health player (Accu-Chek, insulin delivery, connected care). Overlaps with Theras's diabetes portfolio in glucose monitoring and insulin delivery adjacent to Omnipod/Dexcom.
- A. Menarini IFR (Menarini Group): Italian pharmaceutical and diagnostics group with medical device and consumer health adjacencies (e.g., glucose monitoring). Comparable to Theras as an Italy-based healthcare company spanning prescription and consumer channels.
- Nestlé Health Science: Global medical nutrition and weight management player. Comparable to Theras's Plenity weight management portfolio as an adjacent non-pharmacological approach to obesity care, although at much larger scale and with broader nutrition products.
- Ypsomed Holding AG: Swiss diabetes device company (insulin pumps, pen needles, infusion sets). Comparable to Theras's diabetes device distribution business, though Ypsomed is a manufacturer with global reach rather than an Italian-focused distributor.
- Abbott Diabetes Care: Global MedTech division behind FreeStyle Libre CGM systems that compete directly with the Dexcom devices Theras distributes in Italy, and shape the AID ecosystem Theras sells into.
Direct peers
- Sapio Life (Sapio Group): Italian group active in homecare medical devices, oxygen therapy, and hospital medtech distribution. Comparable to Theras in serving chronic disease patients via HCP and home distribution channels in Italy.
- Vivisol (Sol Group): Italian home medical services and device provider for chronic care (respiratory, sleep, diabetes). Comparable as a chronic disease-focused MedTech and homecare service provider operating in Italy.
- Movi SpA: Italian medical device distributor serving hospitals and pharmacies with diabetes, infusion, and specialty devices. Highly comparable to Theras as a domestic multi-category MedTech distributor with hospital and pharmacy channels.
Others
- Insulet Corporation: Manufacturer of the Omnipod tubeless insulin pump system that Theras distributes in Italy; both partner and indirect competitor since Insulet controls the core IP and global commercial strategy.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Theras Group social profiles
Digital presenceTheras Group compliance and trust
Trust signalCompliance5 records
Theras Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Theras Group leadership team
Management profileNumber of profiles
Profiles5 records
Theras Group subsidiaries and ownership
Company hierarchySubsidiaries1 record
Theras Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Theras Group M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Theras Group
What does Theras Group do?
Theras Group distributes and supports an integrated portfolio of medical devices for chronic disease management across diabetes (insulin pumps, continuous glucose monitors, injection access ports), chronic pain (spinal cord stimulation, percutaneous neurostimulation, epidural catheters), and weight management (ingestible hydrogel devices), complemented by a Medical Selfcare line of syringes, wound care, and home health products. The TherasCare ecosystem (24/7 hotline, portal, app, AI chatbot) and professional education programs (Theras Academy, Scientific Talks) provide ongoing patient and clinician support alongside device distribution.
Is Theras Group a public or private company?
Theras Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Theras Group founded?
Theras Group was founded in 2010. It employs 101 to 250 people.
Where is Theras Group based?
Theras Group is headquartered in Parma, Italy, in the Europe region.
How does Theras Group make money?
Three revenue lines are on record. Medical Device Distribution is the primary driver. The others are product Portfolio Sales and therasCare Support Services.
Who are Theras Group's main competitors?
Broad incumbents on record are Medtronic plc, Roche Diabetes Care, A. Menarini IFR (Menarini Group), Nestlé Health Science, Ypsomed Holding AG and Abbott Diabetes Care. Direct peers are Sapio Life (Sapio Group), Vivisol (Sol Group) and Movi SpA. Insulet Corporation is listed as an others.
Does Theras Group have an API?
No public API is recorded for Theras Group.
What industry is Theras Group in?
Theras Group's product category is Medical Device Distribution and Chronic Disease Management. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAKADAA, Diabetes (General). Its NAICS code is 62 and its SIC code is 3841.